European Investment Bank

Marinomed is a biopharmaceutical development company focusing on the development of innovative therapies based on patent protected technology platforms. Products against respiratory viruses derived from the proprietary MAVIREX platform are marketed with renowned partners in a growing number of countries around the globe. The new MARINOSOLV platform allows novel stable aqueous formulations of hardly soluble compounds such as corticosteroids, enabling a faster onset of action and a better bioavailability. The MARINOSOLV technology is not limited to a specific compound and has the potential to facilitate delivery of any compound with solubility issues. Marinomed was founded on 2006 and is headquartered in Vienna, Austria.

Enpal GmbH, founded in 2017 and based in Berlin, Germany, specializes in providing all-in-one renewable energy solutions, including solar panels, battery systems, wallboxes, heat pumps, and energy management systems. The company focuses on making renewable energy accessible and affordable for customers in Germany and Italy through a unique leasing model that requires no upfront payment. This model covers installation, insurance, and maintenance, attracting customers who prefer to avoid high initial investments. Enpal has successfully installed over 60,000 solar photovoltaic systems, becoming the market leader in Germany. The company employs more than 1,000 staff, including over 200 local installer teams, and has opened several satellite offices to enhance customer service. Enpal has received numerous accolades, including awards for sustainability and customer service. In recent years, it has diversified its offerings and introduced a sales option to accommodate customers interested in purchasing their solar solutions. In 2022, Enpal reported revenues exceeding 400 million euros and has been recognized as one of Germany's fastest-growing companies.

NVision Imaging Technologies GmbH, founded in 2015 and based in Ulm, Germany, specializes in the development and commercialization of innovative imaging and sensing applications grounded in quantum physics. The company has created a platform that polarizes natural metabolites, enabling their use as agents for imaging tumor metabolism through magnetic resonance imaging (MRI). This technology transforms standard magnetic resonance spectrometers into tools capable of assessing human metabolism, thereby enhancing the precision of cancer diagnostics and facilitating real-time monitoring of patient responses to therapy. By leveraging advances in quantum physics, NVision aims to make significant strides in the medical imaging and diagnostics sector.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in the manufacture of surgical equipment aimed at enhancing the safety of transcatheter aortic valve replacement (TAVR) procedures. The company has developed the ProtEmbo System, an intra-aortic filter device designed to mitigate the risk of cerebrovascular events during TAVR by deflecting embolic material away from the cerebral circulation. This innovation addresses a significant complication associated with TAVR, which has become a preferred treatment for patients with valvular heart disease, particularly as the procedure is increasingly performed on younger and lower-risk individuals. By minimizing the risk of brain injury, Protembis aims to improve patient outcomes and reduce healthcare costs related to surgical complications.

Evonik Industries AG is a leading German chemical company specializing in the production of specialty chemicals used across various industries, including nutrition, healthcare, and resource efficiency. The company operates in over 100 countries and is a market leader in approximately 80% of its business segments, which include specialty additives, smart materials, nutrition and care, and performance materials. Evonik's innovative approaches and integrated technology platforms enable it to offer diverse products, such as animal nutrition, high-performance polymers, and sustainable solutions. With a strong presence in Europe, North America, and Asia, Evonik generates a significant portion of its revenue from these key markets. The company continues to focus on addressing megatrends such as health, nutrition, and sustainability, positioning itself for ongoing growth and leadership in the specialty chemicals sector.

Ignitis Group is an international energy corporation that manufactures, distributes, supplies, and provides various energy-related services. Ignitis Group was founded in 2019 and is located in Vilnius, Lithuania.

Antibiotice S.A. is a Romanian pharmaceutical company that specializes in the development and manufacturing of generic drugs. Established in 1955 and headquartered in Iasi, the firm offers a diverse portfolio of approximately 150 medicines across 12 therapeutic classes, including cardiovascular, central nervous system, digestive tract, anti-inflammatory, dermatological, oncological, and pain management medications. In addition to human medicines, the company produces veterinary drugs and the active pharmaceutical ingredient Nystatin. Antibiotice's product forms include sterile injectable powders, capsules, tablets, ointments, gels, creams, suppositories, and pessaries. The company exports its products to around 75 countries, reflecting its commitment to addressing a wide range of health needs globally.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Garanti BBVA Romania is a dynamic bank in the local market, offering a comprehensive range of banking and financial services to clients in Bucharest. The bank provides quality products for various sectors, including retail, small and medium-sized enterprises (IMM), and corporate clients. Its services encompass debit cards, bank accounts, loans, financing solutions, financial risk protection, and payment systems, effectively catering to the needs of both individuals and businesses.

Wingcopter GmbH, founded in 2014 and based in Darmstadt, Germany, specializes in the development and manufacture of advanced delivery drones for various applications, including medical supply chains and last-mile logistics. The company produces eVTOL, fixed-wing unmanned aircraft systems designed to efficiently deliver medicines, vaccines, blood, lab samples, parcels, and food to remote locations, as well as conduct inspections of public infrastructure. Its flagship model, the Wingcopter 198, features a patented tilt-rotor mechanism that allows for vertical takeoff and landing while maintaining the efficiency and range of a fixed-wing aircraft, even under challenging weather conditions. With a dedicated team of 120 professionals, Wingcopter aims to enhance and save lives through both commercial and humanitarian efforts, earning recognition as a Technology Pioneer by the World Economic Forum in 2020.

AT&S is a Europe-based printed circuit board manufacturer focused on high-end printed circuit board technology. Depending on technological and economic requirements, the company offers the widest possible range of printed circuit boards specially tailored to customers’ needs such as double-sided plated-through, multi-layer, high density interconnection and laser-drilled, insulated metallic substrate, flexible, rigid-flex, and semi-flexible. The core businesses of AT&S are mobile devices and substrates, automotive, industrial, medical, aviation, and advanced packaging. It has approximately 7,300 employees, of which around 1,200 are in Austria. In the 2013 and 2014 financial year AT&S’s sales revenues totaled 590 million euros, and earnings before interest and tax were 53.9 million euros. AT&S is headquartered in Leoben, Austria.

Smart Reporting GmbH is a Munich-based company that specializes in providing an online platform for structured medical reporting, primarily targeting radiology and pathology. Founded in 2014, the company offers an intelligent software solution that aids physicians in generating high-quality medical reports. The platform features automatic text suggestions, medically accurate terminology, and targeted illustrations, ensuring reports meet established guidelines. Additionally, Smart Reporting assists hospitals and medical practices in implementing report quality standards, optimizing report templates, and integrating with existing systems. The company also provides advanced statistical tools for quality assurance, multilingual reporting, and customizable templates. Furthermore, it offers solutions for medical registries and clinical studies, enabling simultaneous report generation and data submission while facilitating systematic quality assurance. Overall, Smart Reporting enhances the efficiency and quality of medical reporting, ultimately improving communication within healthcare settings.

SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.

GeNeuro is a biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to pathogenic proteins originating from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody designed to treat multiple sclerosis, while temelimab is another candidate that neutralizes a pathogenic protein from the HERV-W family. Additionally, GeNeuro is engaged in developing diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, the company is committed to addressing the underlying factors that drive the progression of neurodegenerative and autoimmune diseases.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

SpinDiag GmbH is a medical technology company based in Freiburg, Germany, focused on developing automated point-of-care systems for the rapid and reliable detection of infectious diseases. Founded in 2016, the company has created a centrifugal-microfluidic test system that allows healthcare providers to screen for the 25 most common antibiotic resistances directly from patient samples upon hospital admission. This innovative system helps prevent the spread of drug-resistant bacteria by enabling the immediate isolation of infected patients. SpinDiag's first product is an automated SARS-CoV-2 test that provides laboratory-grade PCR results directly from standard patient swab samples, streamlining the workflow for nurses and integrating seamlessly into clinical practice. The fully automated system eliminates the need for manual pipetting, thereby minimizing the risk of infection and enhancing the efficiency of pathogen detection in hospital settings.

Autonom Group is a family-owned mobility network that specializes in transportation and car rental services across Romania, Hungary, and Serbia. The company offers a comprehensive range of services, including car rentals, purchase-use vehicles, operating leases, equipment leases, road assistance, transfer services, and fleet management. Autonom Group is committed to long-term growth driven by client satisfaction and the development of its employees. The company prioritizes profitability and financial stability as natural outcomes of its focus on customer service and employee evolution.

Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.

Blickfeld is a Munich-based company that specializes in producing LiDAR sensors and detection software for autonomous mobility and Internet of Things (IoT) applications. Founded in 2017, Blickfeld's technology utilizes patented silicon MEMS mirrors along with commercial off-the-shelf components to create cost-effective laser range scanners. These sensors are designed to measure direct distance information in three dimensions, enabling high-definition geometric mapping and object detection. Blickfeld's innovative approach allows for the mass production of low-cost LiDAR systems that meet stringent automotive performance standards, making advanced technology accessible for the autonomous driving market.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

InstaFreight GmbH is a Berlin-based company that specializes in providing online freight forwarding services to B2B customers. Founded in 2016, InstaFreight aims to simplify the booking and processing of freight transport, making it fast and straightforward for businesses. The company focuses on delivering reliability, quality, and transparency, striving to become Europe's leading online freight forwarder. By offering innovative solutions and exceptional service, InstaFreight reduces the complexity of supply chains and enhances transparency for both customers and carriers.

TRUMPF is a high-technology company based in Ditzingen, Germany, specializing in the manufacturing of machine tools, industrial lasers, and medical technologies. Renowned as a leader in flexible sheet metal processing, TRUMPF is committed to advancing digital connectivity within the manufacturing industry through innovative consulting, platforms, and software solutions. As a family-owned enterprise, it emphasizes long-term thinking and sustainable growth, bolstering its reputation for continuous innovation. TRUMPF Venture, the company's corporate venture capital arm, aims to foster innovation by investing globally in early-stage startups that align with TRUMPF's core business areas, including photonics, manufacturing technology, and industrial software systems. The venture arm seeks companies with a strategic fit, strong management teams, and potential for significant market differentiation, providing these startups access to TRUMPF's extensive network and expertise to enhance their scalability and success.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Ørsted is a Danish company specializing in the development and maintenance of offshore and onshore renewable energy farms, energy storage facilities, and bioenergy plants. Formerly known as DONG Energy, Ørsted has undergone a significant transformation over the past decade, committing to a vision of a world powered entirely by green energy. The company has dramatically reduced its coal consumption by 73% and aims to completely phase out coal by 2023. As a global leader in offshore wind, Ørsted holds a 25% market share, providing energy to approximately 9.5 million people. By the end of 2023, Ørsted operated 8.9 gigawatts of offshore wind capacity, with the United Kingdom being its largest market, followed by Germany and Denmark. The company is also expanding its presence outside Europe with projects in Taiwan and the United States, where it operates 4.8 gigawatts of onshore wind and solar assets. In addition to its renewable initiatives, Ørsted still engages in traditional utilities, including conventional power plants.

Robart is an Austrian high-tech start-up established in 2009, dedicated to creating autonomous mobile robots for both consumer and industrial use, leveraging its proprietary Artificial Intelligence Control Unit (AICU) technology. The company aims to revolutionize everyday life by developing affordable robotic solutions, including intelligent vacuum cleaners and security robots, that can effectively navigate and adapt to dynamic home environments. By focusing on robust functionality and intuitive user interaction, Robart addresses the shortcomings of current robotic offerings, ensuring that its products not only meet but exceed consumer expectations. The company's innovative approach positions it as a key player in the next generation of intelligent robotics, with a vision of making a robot accessible for every household.

Magazino GmbH, founded in 2014 and based in Munich, Germany, specializes in developing and manufacturing mobile robots for the storage and intralogistics sectors. The company offers advanced mobile pick-and-place robots designed for e-commerce warehouses, capable of identifying and localizing individual items using 2D and 3D cameras. These robots operate collaboratively as part of a swarm, utilizing the ACROS (Advanced Cooperative Robot Operating System) to receive and execute orders. Additionally, Magazino provides the App ARC (ACROS Robot Control) for monitoring robot fleets. Their technology aims to simplify and automate daily operations for mail-order companies, warehouses, production lines, and pharmacies, ultimately contributing to the evolution of robotics and the future of logistics.

Scope Fluidics S.A., founded in 2010 in Warsaw, Poland, specializes in the development and manufacturing of innovative diagnostic devices that leverage microfluidic technology. The company creates disposable systems designed for the efficient collection of micro-samples of blood and the storage of reagents for various diagnostic markers. It aims to address global health challenges by integrating insights from academia and medical practices to produce high-potential solutions. Scope Fluidics operates through two special purpose vehicles, Curiosity Diagnostics and Bacteromic, which focus on specific projects in diagnostics and med tech. The organization fosters collaboration among physicians, engineers, and scientists to develop effective responses to market needs and social requirements in healthcare.

NavVis is a technology company based in Munich, Germany, specializing in indoor spatial intelligence and digital twin solutions. The company offers mobile mapping systems that utilize simultaneous localization and mapping (SLAM) technology to generate high-quality, survey-grade data quickly and efficiently. Its platform is designed to assist service providers and enterprises in capturing and sharing the built environment as photorealistic digital twins, enabling better operational decisions and increased productivity. NavVis's digital factory solutions facilitate improved business processes and profitability for clients in industries such as surveying, architecture, engineering, construction, and manufacturing. With additional offices in the United States and China, NavVis serves a global customer base, providing tools for accurate 3D mapping and immersive visualization of industrial facilities.

CureVac is a clinical-stage biopharmaceutical company based in Germany, focused on developing vaccines and therapies utilizing messenger RNA (mRNA). Founded in 2000, the company’s innovative approach involves using mRNA as a data carrier to instruct the body to produce proteins that can combat various diseases. CureVac's pipeline includes novel mRNA-based cancer immunotherapies, prophylactic vaccines for infectious diseases, and molecular therapies aimed at enhancing the body’s production of therapeutic proteins. Its most advanced candidate, CV9104, is currently in Phase IIb clinical trials for prostate cancer treatment. Additionally, CureVac has collaborated with GSK to create second-generation vaccines for seasonal influenza and COVID-19, as well as an avian influenza vaccine, while exploring other mRNA vaccine applications in oncology and various therapeutic areas.

BioNTech is a biotechnology company based in Germany that specializes in developing innovative therapies for cancer and infectious diseases, including COVID-19. The company is known for its focus on individualized immunotherapy and has a diverse oncology pipeline that features various classes of drugs, such as mRNA-based therapeutics that encode antigens and neoantigens, as well as cytokines, antibodies, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech's notable achievement includes the commercialization of its COVID-19 vaccine, Comirnaty. Additionally, the company collaborates with several major pharmaceutical firms, enhancing its capabilities and reach in the biopharmaceutical industry.

Resalta is an energy efficiency company based in Ljubljana-Črnuče, Slovenia, founded in 2011. The company focuses on reducing environmental footprints and managing energy consumption for clients across various sectors, including food, manufacturing, automotive, and finance. Resalta designs energy efficiency projects tailored to the specific consumption needs of its clients, ensuring that solutions are both innovative and reliable. Additionally, the company develops and implements renewable energy projects to enhance the use of sustainable energy sources in the countries where it operates. By providing comprehensive services in energy efficiency and renewable energy, Resalta aims to improve clients' competitiveness and overall environmental impact.

ITM Isotopen Technologien München AG is a privately held biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radionuclides and -generator platform for a new generation of targeted cancer diagnostics and therapies. ITM’s isotope business is profitable and growing. In July 2016 the European Commission has granted Marketing Authorization for EndolucinBeta® of ITM´s subsidiary ITG Isotope Technologies Garching GmbH. EndolucinBeta® respectively no-carrier-added (n.c.a.) Lutetium (177Lu) chloride is a radiopharmaceutical precursor and is used in Targeted Radionuclide Therapy. The drug approval is an important milestone for ITM as a specialized radiopharmaceutical company. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development, which address a range of cancers such as neuroendocrine cancers or bone metastases. ITM’s main objectives, together with its scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology.

Telefónica Deutschland offers mobile and fixed services for private and business customers, as well as innovative digital products and services in the fields of Internet of Things and data analytics. With a total of 49.6 million1) customer lines, the company is one of the leading integrated telecommunications providers. In the mobile segment alone, Telefónica Deutschland is responsible for more than 45 million1) lines. Telefónica Deutschland will become the "Mobile Customer & Digital Champion" – with this aspiration, the company intends to become the preferred customer partner in the German mobile service market by 2022. This is linked to a clear mandate that Telefónica Deutschland will make its customers’ lives easier and better and allows them mobile freedom in the digital world. In concrete terms, this means a consistently positive experience with the brand, products, customer service and network. The company already has an excellent foundation to reach this goal. No network operator in Germany connects more people with mobile services. Following the integration of E-Plus, the company is digitalising its business model while consistently focusing on customer benefit.

BioNTech is a biotechnology company based in Germany that specializes in developing innovative therapies for cancer and infectious diseases, including COVID-19. The company is known for its focus on individualized immunotherapy and has a diverse oncology pipeline that features various classes of drugs, such as mRNA-based therapeutics that encode antigens and neoantigens, as well as cytokines, antibodies, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech's notable achievement includes the commercialization of its COVID-19 vaccine, Comirnaty. Additionally, the company collaborates with several major pharmaceutical firms, enhancing its capabilities and reach in the biopharmaceutical industry.

Bitmovin Inc specializes in online streaming solutions and server encoding systems, focusing on enhancing the performance and delivery of video content. Founded in 2012, the company offers a cloud-based transcoding platform known as bitcodin, which supports adaptive streaming formats like MPEG-DASH and Apple HLS. Its product suite includes BITDASH, optimized clients for various platforms, and LIBDASH, an official ISO/IEC MPEG-DASH reference software. Additionally, Bitmovin provides an Encoding API for real-time content encoding, a Player for delivering video to devices, and Analytics tools to improve viewer engagement through actionable insights. With offices in San Francisco and Klagenfurt, Austria, Bitmovin also engages in consulting and standardization services related to multimedia technologies, leveraging a strong connection to academic research in the field. The company has formed a strategic partnership with Intertrust Technologies Corporation and is backed by notable investors.

FAZUA GmbH is a company that develops and manufactures innovative e-bike drive systems, aiming to enhance cycling mobility while preserving the natural feel of traditional biking. Founded in 2011 and headquartered in Munich, Germany, FAZUA's flagship product, the evation drive system, integrates an engine, gearbox, battery, and power electronics that can be easily removed and replaced with a cover. This design allows bike manufacturers to create sleek frames that discreetly house the drive system in the downtube. The company focuses on meeting the demands of sporty cyclists while providing a seamless transition between motorized and non-motorized riding experiences.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

tado° GmbH is a Munich-based company that specializes in developing and marketing home climate control systems. Founded in 2010, the company offers a combination of hardware and software solutions designed to enhance the efficiency of heating and cooling systems in residential and small business environments. tado°'s innovative products adjust to the behavior of residents in real time while also considering weather forecasts and building characteristics. The company distributes its offerings through both retail stores and online platforms, positioning itself at the intersection of technology and sustainable energy management in the cleantech market. With an additional office in London, tado° continues to focus on integrating Internet of Things technology into everyday climate control solutions.

Nokia is a Finnish multinational communications corporation that specializes in manufacturing mobile devices, network infrastructure, and advanced technologies. The company offers a diverse range of products and services designed to enhance communication and connectivity, including mobile broadband, global services, location-based technologies, and technology licensing. Its mobile broadband segment provides essential hardware and core network software for mobile voice and data services, while the global services segment focuses on network implementation, management, and optimization. Nokia's HERE segment is dedicated to developing local commerce and location-based services. The company operates in over 150 countries and has significant manufacturing facilities in locations such as India, China, Finland, and Germany. Additionally, Nokia maintains a robust research division and a patent business, contributing to its role as a key player in the telecommunications industry.

Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

medneo GmbH is a Berlin-based company that specializes in diagnostic imaging services, focusing on "radiology as a service." Rather than selling imaging equipment, medneo provides pay-per-use solutions for diagnostic image acquisition and reporting to radiologists, medical centers, and hospitals. Its innovative approach enhances operational efficiency, improves the utilization of imaging equipment, and delivers high-quality medical images and services at lower costs. This model not only streamlines the imaging process for healthcare providers but also improves patient access to radiology services, significantly reducing waiting times. Through its network of diagnostic centers and teleradiology sites, medneo aims to support healthcare professionals and institutions with comprehensive imaging solutions tailored to their needs.